Cargando…
Integrated Meta-Omics Analysis Unveils the Pathways Modulating Tumorigenesis and Proliferation in High-Grade Meningioma
Meningioma, a primary brain tumor, is commonly encountered and accounts for 39% of overall CNS tumors. Despite significant progress in clinical research, conventional surgical and clinical interventions remain the primary treatment options for meningioma. Several proteomics and transcriptomics studi...
Autores principales: | Biswas, Deeptarup, Halder, Ankit, Barpanda, Abhilash, Ghosh, Susmita, Chauhan, Aparna, Bhat, Lipika, Epari, Sridhar, Shetty, Prakash, Moiyadi, Aliasgar, Ball, Graham Roy, Srivastava, Sanjeeva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604908/ https://www.ncbi.nlm.nih.gov/pubmed/37887327 http://dx.doi.org/10.3390/cells12202483 |
Ejemplares similares
-
A large-scale targeted proteomics of serum and tissue shows the utility of classifying high grade and low grade meningioma tumors
por: Halder, Ankit, et al.
Publicado: (2023) -
Comprehending Meningioma Signaling Cascades Using Multipronged Proteomics Approaches & Targeted Validation of Potential Markers
por: Mukherjee, Shuvolina, et al.
Publicado: (2020) -
Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers
por: Sharma, Samridhi, et al.
Publicado: (2014) -
Deep proteome investigation of high-grade gliomas reveals heterogeneity driving differential metabolism of 5-aminolevulinic acid
por: Ghantasala, Saicharan, et al.
Publicado: (2023) -
Multiple Reaction Monitoring-Based Targeted Assays for the Validation of Protein Biomarkers in Brain Tumors
por: Ghantasala, Saicharan, et al.
Publicado: (2021)